1. DIABETES
  - As of 2022, the Centers for Disease Control and Prevention (CDC) reports that approximately [38 million] Americans are living with diabetes. [ 90% to 95% ] use portables and sensors to manage their glucose.

 

2. CARDIOVASCULAR DISEASES
  - The American Heart Association states that cardiovascular diseases (CVD) affect [121 million ] of the U.S. population.
  - [X%] of CVD patients are participating in remote patient monitoring programs to enhance their overall cardiovascular health (Reference: heart.gov).

​

3. RENAL DISEASES
  - The National Kidney Foundation estimates that [15 million] Americans have chronic kidney disease (CKD).
  - [1 to 5%] of CKD patients are utilizing remote patient monitoring technologies to track and manage their renal health.

 

​

OVERALL TRENDS: 
 

Remote patient monitoring has shown a consistent rise across various chronic conditions, offering patients real-time data and healthcare professionals valuable insights. The adoption of telehealth and remote monitoring has notably increased, especially in response to the COVID-19 pandemic.

​

These statistics underscore the growing reliance on remote patient monitoring technologies among individuals managing diabetes, cardiovascular diseases, and renal conditions. For the most up-to-date and specific data, please refer to the latest reports and publications from reputable health organizations and government agencies at HHS.gov. 

​

A 2021 study from Mayo Clinic revealed that COVID-19 patients participating in an RPHM program experienced fewer ER visits and hospitalizations. Within 30 days of enrollment, there were nearly 11.4% ER visits, 9.4% hospitalizations, and 0.4% fatalities.

​

It's important to note that the effectiveness of patient health monitoring may vary from person to person, and its success also depends on factors such as patient engagement, compliance, and the quality of the remote monitoring system in use. Furthermore, RPHM should always be integrated into a comprehensive healthcare approach, with regular communication between patients and healthcare providers. Research conducted by the Mayo Clinic, the American Medical Association (AMA), and the National Institutes of Health (NIH) demonstrates a positive impact of Remote Patient Health Monitoring (RPM) on patients with chronic conditions.

​

Emerging research underscores the profound potential of Remote Patient Monitoring in effecting remarkable reductions in both systolic blood pressure (SBP) and diastolic blood pressure (DBP) when compared with customary care and standalone self-monitoring. Direct comparisons against conventional care consistently manifest noteworthy average decreases in both SBP and DBP through the implementation of RPM. Within comprehensive three-way analyses, albeit solitary self-monitoring exhibits modestly favorable effects on blood pressure regulation vis-à-vis standard care, the synergistic integration of RPM unveils a substantially more pronounced influence on SBP and DBP compared to self-monitoring in isolation. Furthermore, supplementary investigations accentuate that the salutary impact of RHPM on SBP could potentially attain greater ascendancy with prolonged intervention durations and the assimilation of multifaceted behavior modification modalities.